Insights to Clinical Use of Serial Determination in Titers of Cyclic Citrullinated Peptide Autoantibodies
Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out. Thus, we investigated the serial determination in anti-CCP antibodies titer...
Saved in:
Main Authors: | Toshiaki Kogure, Takeshi Tatsumi, Hiroshi Fujinaga, Atsushi Niizawa, Katsutoshi Terasawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2007/12367 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No Correlation Exists between Disease Activity and the Expression of Killer-Cell
Immunoglobulin-Like Receptors in Patients with Rheumatoid Arthritis
by: Toshiaki Kogure, et al.
Published: (2007-01-01) -
Killer-Cell Inhibitory Receptors, CD158a/b, are Upregulated by Interleukin-2, but not Interferon-γ or Interleukin-4
by: Toshiaki Kogure, et al.
Published: (1999-01-01) -
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis
by: Alberto Daniel Rocha-Muñoz, et al.
Published: (2015-01-01) -
Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
by: Gokhan Sargin, et al.
Published: (2018-01-01) -
Gene expression of cell surface antigens in the early phase of murine influenza
pneumonia determined by a cDNA expression array technique
by: Shinya Sakai, et al.
Published: (2002-01-01)